ArticleFrontiers in oncology2020

Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine-N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients.

Mervat M Omran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.